Selank for Sale: The Listing Field That Reports 12.29 mg

Read the fields in this order. The first three establish what the object is, the next three establish that the quantity is real, and the last two establish whether anything can be checked after the box arrives.

The last row is the one that inverts most buyers' instincts. A seller describing what the compound will do for you is not being more helpful. It is advertising an unapproved drug, and a seller comfortable doing that is a seller whose other statements carry less weight, not more.

The listing states Selank 10 mg, lyophilised. Dry powder rather than a solution is doing real work here. It is stable at ambient temperature for shipping, it has no fill volume anyone else has chosen for you, and it has no preservative question, because there is nothing yet for anything to grow in.

Then comes the unusual field. Both published certificates for this product report a weighed quantity, and both come in above the label.

Publishing a measured mass at all is rare, and publishing one that exceeds the label is rarer still, because it invites exactly the question a seller would rather avoid: which number am I buying? The honest answer is the label. An overfill is a property of a batch on a date, not a term of sale, and nothing on the listing commits to it. Compare vendors on $2.38 and treat $1.93 as what one specific lot turned out to contain.

Note also what the assay does not cover. The MZ Biolabs document carries the laboratory's own note that salts and sugars added to aid solubility and buffer pH are not normally detected by UV and are not counted as impurities, so total vial contents and UV-detectable Selank are two different masses. Formats can hide quantity in the other direction too, which is the whole subject of our BPC-157 listing breakdown, where a stack and a single-peptide vial are advertised with the same name and the same number.

This is the field almost nobody checks and the field that changes the most. Ascension publishes two third-party certificates against the Selank listing, and they do not test the same things.

Two lots of the same product, two very different evidence packages. The sterility row is narrower than a pass makes it sound, and the report says so itself: the method is a preliminary screen suitable for quality control, with full compendial testing possibly required for regulatory compliance. That is why the lot code is not administrative trivia: it is the string that decides which of those two columns describes the vial in your hand. Compare it character by character against the certificate before treating any figure on that document as yours.

A listing that publishes no lot code at all, or one site-wide PDF for every batch it has ever sold, has not failed a formality. It has made all of its other numbers unverifiable in a way you cannot detect from the outside. The same test applied to a gram-scale product is worked through in our NAD+ listing read, where the missing field is grade rather than lot.

Purity, identity and quantity answer the question of whether you received the right molecule in the stated amount. They say nothing about what else travelled with it, and on this compound FDA has been specific about why that matters.

On its page covering bulk drug substances that may present significant safety risks, current as of 22 April 2026, the agency states that compounded drugs containing selank acetate may pose a risk for immunogenicity for certain routes of administration, due to the potential for aggregation and peptide-related impurities, and that it lacks important information regarding any safety issues raised by selank acetate administered to humans.

Immunogenicity is an immune response to something the body reads as foreign. Aggregates and synthesis-related impurities can provoke one, and so can endotoxin, which is lipopolysaccharide debris from Gram-negative bacteria. Endotoxin survives conditions that kill the organism that produced it, which is exactly why sterility and endotoxin are separate tests, and why a certificate carrying one is not carrying the other.

Some arithmetic on the purity line makes the impurity point concrete. The February certificate shows two peaks: 99.32% of UV-detected material at 7.13 minutes and 0.68% at 6.36 minutes. Applied to the measured 12.29 mg, that second peak is roughly 84 micrograms per vial of something that is not Selank and was not identified. That is a small number in absolute terms and an unignorable one in a discussion about peptide-related impurities.

None of this converts research material into anything usable in a person. The endotoxin line lets you rank two suppliers. It clears nothing, and FDA's statement about lacking information on human safety is not addressed by any laboratory report.

Two operational fields separate a seller holding stock from an intermediary who orders yours after your money clears.

• A dispatch cut-off, not a processing window. Same-day dispatch before 2pm CST is a commitment against a clock. Ships within 1 to 3 business days is a description of a queue, and often of a drop-ship arrangement where the vial has not been bought yet.
• Stock status and origin. In stock plus a domestic origin means no border between the seller and you, which removes customs from the equation entirely and leaves a return path that exists.
• Storage conditions stated for both states. Lyophilised powder and reconstituted solution are different storage problems, and a listing that addresses only one has thought about only one. Our peptide storage guide covers both.
• Free carriage thresholds. Free shipping starts at $250 here, which a five-vial tier order at $225.63 misses by $24.37 and a ten-vial order at $427.50 clears.

Equally important is what the listing does not promise, and should not. No efficacy claim, no route of administration, no suggested quantity, no mention of what any of it might do for a person. A Selank nasal spray for sale on a consumer nootropic site will usually promise all four, which is a marketing decision with regulatory implications rather than evidence of a better product.

Every field above exists to make one division trustworthy: total paid divided by milligrams received. Here is that division on the listing as it stands.

The tiers discount the list price and the code discounts a single vial, so the ladder never reaches the code. Whether the two combine at checkout is undocumented, which makes the cart total the only authority worth quoting. Our Selank price page runs the division in both directions, including what the measured masses do to it.

After that the unit changes from money to volume, and the vial stops being a purchase and starts being laboratory handling arithmetic. Ten milligrams reconstituted at 2 mL is 5 mg/mL, so one unit on a U-100 barrel holds 50 micrograms and ten units hold 500. Half a milligram costs $1.19 at the code rate no matter what volume you chose, because dilution changes resolution rather than cost. The Selank calculator handles any volume, and the Selank reference page carries the compound data.